Nutrien Q4 Adj EPS $0.37 Misses $0.65 Estimate, Sales $5.66B Beat $5.35B Estimate
Portfolio Pulse from Benzinga Newsdesk
Nutrien (NYSE:NTR) reported Q4 adjusted earnings per share of $0.37, missing the consensus estimate of $0.65, representing an 81.68% decrease from the same period last year. However, their quarterly sales of $5.66 billion exceeded the consensus estimate of $5.35 billion by 5.96%, despite being a 24.81% decrease from the previous year.
February 21, 2024 | 10:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Nutrien's Q4 adjusted EPS of $0.37 missed the consensus estimate of $0.65, and sales of $5.66B exceeded estimates. Earnings decreased by 81.68% YOY, while sales decreased by 24.81%.
The significant miss in EPS is likely to negatively impact investor sentiment in the short term, despite the sales beat. The substantial year-over-year decrease in both earnings and sales further compounds the negative outlook, suggesting a bearish short-term impact on NTR's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100